Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia

BACKGROUND: The granulocyte-colony stimulating factor (G-CSF) biosimilar filgrastim (Nivestim™) reduces the duration and severity of neutropenia and the frequency of occurrence of febrile neutropenia (FN). Administration of this biosimilar filgrastim and the patient population receiving it at home h...

Full description

Saved in:
Bibliographic Details
Published in:Patient Prefer Adherence
Main Authors: Otremba, Burkhard, Hielscher, Carsten, Petersen, Volker, Petrik, Christian
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2018
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199230/
https://ncbi.nlm.nih.gov/pubmed/30410313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S168029
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items